Greg Milosevich
Directeur/Membre du Conseil chez Molecular Devices (UK) Ltd.
Profil
Greg Milosevich is currently the Director at Molecular Devices (UK) Ltd.
He previously held positions as President at Molecular Devices LLC and President at Beckman Coulter Life Sciences from 2019 to 2022.
He also served as Vice President-Worldwide Sales at Biotheranostics, Inc. Mr. Milosevich completed his undergraduate degree at the University of Puget Sound.
Postes actifs de Greg Milosevich
| Sociétés | Poste | Début |
|---|---|---|
Molecular Devices (UK) Ltd.
 Molecular Devices (UK) Ltd. Medical SpecialtiesHealth Technology Part of Danaher Corp., Molecular Devices (UK) Ltd. is a British company that develops molecular devices for life science research, pharmaceutical and bio therapeutic development. The company is based in Wokingham, UK and was founded in 1993. | Directeur/Membre du Conseil | 23/03/2017 |
Anciens postes connus de Greg Milosevich
| Sociétés | Poste | Fin |
|---|---|---|
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | President | 13/03/2024 |
Beckman Coulter Life Sciences
 Beckman Coulter Life Sciences Miscellaneous Commercial ServicesCommercial Services Beckman Coulter Life Sciences engages in the development, manufacturing, and marketing of products for biomedical testing. It offers air particle counters, cell counters, sizers, and media analyzers, centrifuges, flow cytometers, automated liquid handling solutions, HIAC liquid particle counters, particle size analyzers, and total organic carbon analyzers. The company is headquartered in Indianapolis, IN. | President | 13/07/2022 |
Molecular Devices LLC
Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | President | 04/06/2019 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Sales & Marketing | - |
Formation de Greg Milosevich
| University of Puget Sound | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Molecular Devices LLC
Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Beckman Coulter Life Sciences
Beckman Coulter Life Sciences Miscellaneous Commercial ServicesCommercial Services Beckman Coulter Life Sciences engages in the development, manufacturing, and marketing of products for biomedical testing. It offers air particle counters, cell counters, sizers, and media analyzers, centrifuges, flow cytometers, automated liquid handling solutions, HIAC liquid particle counters, particle size analyzers, and total organic carbon analyzers. The company is headquartered in Indianapolis, IN. | Commercial Services |
Molecular Devices (UK) Ltd.
Molecular Devices (UK) Ltd. Medical SpecialtiesHealth Technology Part of Danaher Corp., Molecular Devices (UK) Ltd. is a British company that develops molecular devices for life science research, pharmaceutical and bio therapeutic development. The company is based in Wokingham, UK and was founded in 1993. | Health Technology |
